IKARIAN CAPITAL, LLC Celldex Therapeutics, Inc. Transaction History

IKARIAN CAPITAL, LLC portfolio value:

$0
portfolio value

Celldex Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 call Decrease -100.00% -506.5K shares -13.65M $28.11 0
Q3 2022 share Decrease -40.98% -220.48K shares -5.58M $28.11 317.47K
Q3 2022 put Decrease -100.00% -616.7K shares -16.62M $28.11 0
Q2 2022 share 0.00% 0 shares -3.81M $26.96 537.95K
Q2 2022 put Increase +3.56% 21.2K shares -3.65M $26.96 616.7K
Q2 2022 call Increase +47.20% 162.4K shares 1.93M $26.96 506.5K
Q1 2022 put Increase +31.98% 144.3K shares 2.84M $34.06 595.5K
Q1 2022 call Decrease -42.05% -249.7K shares -11.22M $34.06 344.1K
Q1 2022 share Increase +28.32% 118.74K shares 2.12M $34.06 537.95K
Q4 2021 share Increase +55.02% 148.78K shares 1.59M $38.9 419.21K
Q4 2021 call Decrease -24.99% -197.8K shares -19.79M $38.9 593.8K
Q4 2021 put Decrease -13.26% -69K shares -10.65M $38.9 451.2K
Q3 2021 put Increase +3151.25% 504.2K shares 27.54M $53.99 520.2K
Q3 2021 call Increase +31.93% 191.6K shares 22.67M $53.99 791.6K
Q3 2021 share Decrease -26.02% -95.11K shares 2.37M $53.99 270.43K
Q2 2021 call Increase +19.17% 96.5K shares 9.69M $33.44 600K
Q2 2021 share Decrease -38.70% -230.74K shares -60K $33.44 365.54K
Q2 2021 put Increase 0.00% 16K shares 535K $33.44 16K
Q1 2021 call Increase +25.88% 103.5K shares 3.36M $20.6 503.5K
Q1 2021 share Decrease -56.32% -768.7K shares -11.63M $20.6 596.29K
Q4 2020 share Decrease -7.13% -104.74K shares 2.11M $17.52 1.36M
Q4 2020 call Increase +526.96% 336.2K shares 6.06M $17.52 400K
Q3 2020 call Decrease -76.76% -210.7K shares -2.62M $14.83 63.8K
Q3 2020 share Decrease -10.79% -177.70K shares 379K $14.83 1.46M
Q2 2020 share Increase 0.00% 1.64M shares 21.41M $13 1.64M
Q2 2020 call Increase 0.00% 274.5K shares 3.56M $13 274.5K